PHLT · Insider Trading
Performant Healthcare, Inc. Common Stock
Every open-market purchase and sale reported by PHLT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-22 | Eric Yanagi | Director | MIXED | −3,643,510 | — |
| 2025-10-21 | William Dean Hansen | Director | D | −464,115 | — |
| 2025-10-21 | Lisa Im | Director | D | −1,229,413 | — |
| 2025-10-21 | James LaCamp | Director | D | −417,220 | — |
| 2025-10-21 | Shantanu Agrawal | Director | D | −44,430 | — |
| 2025-10-21 | Rohit Ramchandani | Chief Financial Officer | D | −299,101 | — |
| 2025-10-21 | Simeon Kohl | Chief Executive Officer | D | −619,309 | — |
| 2025-10-21 | Bradley M Fluegel | Director | D | −477,610 | — |
| 2025-08-20 | Simeon Kohl | Chief Executive Officer | MIXED | +55,906 | −$272.58K |
| 2025-08-20 | Rohit Ramchandani | Chief Financial Officer | MIXED | +27,209 | −$205.26K |
| 2025-08-15 | Rohit Ramchandani | Chief Financial Officer | MIXED | +7,796 | −$58.82K |
| 2025-08-15 | Simeon Kohl | Chief Executive Officer | MIXED | +12,342 | −$60.18K |
| 2025-08-14 | Simeon Kohl | Chief Executive Officer | MIXED | +31,757 | −$154.95K |
| 2025-08-14 | Rohit Ramchandani | Chief Financial Officer | MIXED | +10,781 | −$81.39K |
| 2025-08-13 | Simeon Kohl | Chief Executive Officer | MIXED | +49,377 | −$241.39K |
| 2025-08-13 | Rohit Ramchandani | Chief Financial Officer | MIXED | +19,800 | −$149.77K |
| 2025-07-28 | Bradley M Fluegel | Director | A | +35,616 deriv. | — |
| 2025-07-28 | Shantanu Agrawal | Director | A | +35,616 deriv. | — |
| 2025-07-28 | William Dean Hansen | Director | A | +35,616 deriv. | — |
| 2025-07-28 | James LaCamp | Director | A | +35,616 deriv. | — |
| 2025-07-28 | Eric Yanagi | Director | J | +35,616 | — |
| 2025-06-04 | Lisa Im | Director | Sell | −180,867 | −$587.82K |
| 2025-05-16 | Simeon Kohl | Chief Executive Officer | MIXED | +45,103 | −$66.72K |
| 2025-05-16 | Rohit Ramchandani | Chief Financial Officer | MIXED | +22,239 | −$46.52K |
| 2025-05-05 | Simeon Kohl | Chief Executive Officer | A | +396,639 deriv. | — |
| 2025-05-05 | Rohit Ramchandani | Chief Financial Officer | A | +183,193 deriv. | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PHLT quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.